CVS Health Corporation (NYSE:CVS) Stock Has Average Target Price of $109.64

CVS Health Corporation (NYSE:CVS) has earned an average rating of “Moderate Buy” from the twenty-two research firms that are covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and nineteen have issued a buy rating on the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $109.64.

A number of research firms have recently issued reports on CVS. Barclays increased their price target on CVS Health from $106.00 to $108.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Wall Street Zen lowered shares of CVS Health from a “strong-buy” rating to a “buy” rating in a report on Monday, October 19th. BMO Capital Markets set a $112.00 price objective on shares of CVS Health in a research note on Wednesday, September 9th. UBS Group restated a “buy” rating on shares of CVS Health in a report on Tuesday, September 22nd. Finally, Leerink Partners dropped their target price on CVS Health from $119.00 to $112.00 and set an “outperform” rating on the stock in a research report on Monday, October 12th.

CVS Health Stock Down 1.9%

Shares of NYSE CVS opened at $88.54 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The firm has a market capitalization of $113.24 billion, a price-to-earnings ratio of 23.42, a PEG ratio of 0.84 and a beta of 0.60. The stock has a 50 day moving average price of $91.13 and a 200 day moving average price of $88.80. CVS Health has a 52-week low of $69.51 and a 52-week high of $110.68.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. The company had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%. CVS Health’s revenue was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Sell-side analysts expect that CVS Health will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were given a $0.6650 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.0%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health’s payout ratio is presently 70.37%.

Institutional Investors Weigh In On CVS Health

A number of institutional investors have recently added to or reduced their stakes in the stock. BlackRock Inc. purchased a new stake in CVS Health during the 2nd quarter worth about $12,747,462,000. State Street Corp raised its position in CVS Health by 26.3% in the 2nd quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock valued at $7,751,205,000 after purchasing an additional 15,604,883 shares in the last quarter. Bank of America Corp DE boosted its stake in shares of CVS Health by 148.0% in the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock valued at $2,398,868,000 after buying an additional 13,836,701 shares during the period. Pzena Investment Management LLC acquired a new position in shares of CVS Health during the second quarter worth about $1,217,558,000. Finally, Wellington Management Group LLP grew its position in shares of CVS Health by 49.8% during the second quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock worth $3,496,725,000 after buying an additional 11,233,381 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.